<div id="readability-page-1"><p>Omega Healthcare Investors, Inc. (NYSE:OHI - Get Free Report) shares reached a new 52-week high during trading on Tuesday . The company traded as high as $46.19 and last traded at $46.0050, with a volume of 1087941 shares. The stock had previously closed at $45.82.</p><h2>Wall Street Analyst Weigh In</h2><ul><li>Top 4 Healthcare REITs Turning Care Into Big Investor Payouts</li></ul><p>OHI has been the subject of several research reports. Raymond James Financial  reissued an &#34;outperform&#34; rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Weiss Ratings  reaffirmed a &#34;buy (b)&#34; rating on shares of Omega Healthcare Investors in a research report on Wednesday, October 8th. Mizuho boosted their price objective on Omega Healthcare Investors from $37.00 to $40.00 and gave the company a &#34;neutral&#34; rating in a research note on Thursday, September 11th. Truist Financial raised their target price on shares of Omega Healthcare Investors from $44.00 to $46.00 and gave the stock a &#34;hold&#34; rating in a research report on Monday. Finally, Wells Fargo &amp; Company lifted their target price on shares of Omega Healthcare Investors from $45.00 to $48.00 and gave the company an &#34;overweight&#34; rating in a report on Tuesday, November 25th. Seven investment analysts have rated the stock with a Buy rating and five have issued  a Hold rating to the company. Based on data from MarketBeat, Omega Healthcare Investors currently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $46.44.</p><p><b>Read Our Latest Report on Omega Healthcare Investors</b></p><h2>Omega Healthcare Investors Trading Up 0.4%</h2><ul><li>Top 3 Stocks to Outperform the S&amp;P 500 in a Downturn</li></ul><p>The company has a 50 day simple moving average of $42.30 and a 200 day simple moving average of $40.18. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $13.60 billion, a PE ratio of 28.40, a P/E/G ratio of 1.85 and a beta of 0.56. </p><p>Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.77 by $0.02. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The business had revenue of $311.59 million for the quarter, compared to analyst estimates of $262.48 million. During the same quarter in the previous year, the company posted $0.71 earnings per share. The company's revenue for the quarter was up 14.4% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS.  Analysts predict that  Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year. </p><h2>Omega Healthcare Investors Announces Dividend</h2><ul><li>6 largest healthcare REITs to buy and how to invest </li></ul><p>The company also recently disclosed a quarterly dividend, which was paid on Monday, November 17th. Shareholders of record on Monday, November 3rd were paid a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 5.8%. The ex-dividend date of this dividend was Monday, November 3rd. Omega Healthcare Investors's payout ratio is currently 149.72%. </p><h2>Insider Buying and Selling at Omega Healthcare Investors</h2><p>In other news, CEO C Taylor Pickett purchased 20,000 shares of the business's stock in a transaction that occurred on Wednesday, November 5th. The stock was purchased at an average cost of $43.14 per share, with a total value of $862,800.00. Following the completion of the acquisition, the chief executive officer directly owned 20,000 shares of the company's stock, valued at approximately $862,800. This trade represents a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CIO Vikas Gupta acquired 11,500 shares of Omega Healthcare Investors stock in a transaction that occurred on Thursday, November 6th. The stock was purchased at an average price of $42.97 per share, with a total value of $494,155.00. Following the transaction, the executive owned 13,773 shares of the company's stock, valued at $591,825.81. This trade represents a 505.94% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 1.50% of the stock is currently owned by company insiders. </p><h2>Hedge Funds Weigh In On Omega Healthcare Investors</h2><p>Several institutional investors and hedge funds have recently added to or reduced their stakes in OHI. Norges Bank acquired a new stake in shares of  Omega Healthcare Investors in the 2nd quarter valued at approximately $121,800,000.  Invesco Ltd. raised its position in  Omega Healthcare Investors by 101.7% in the third quarter. Invesco Ltd. now owns 4,944,921 shares of the real estate investment trust's stock worth $208,775,000 after acquiring an additional 2,493,877 shares in the last quarter.  AQR Capital Management LLC lifted its holdings in  Omega Healthcare Investors by 430.8% in the first quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust's stock valued at $108,989,000 after acquiring an additional 2,322,878 shares during the period.  Hudson Bay Capital Management LP acquired a new stake in  Omega Healthcare Investors in the second quarter valued at $71,312,000.  Finally, JPMorgan Chase &amp; Co. boosted its position in shares of  Omega Healthcare Investors by 77.9% during the 3rd quarter. JPMorgan Chase &amp; Co. now owns 3,417,240 shares of the real estate investment trust's stock worth $144,278,000 after purchasing an additional 1,496,059 shares in the last quarter. Institutional investors and hedge funds own  65.25% of the company's stock. </p><h2>Omega Healthcare Investors Company Profile</h2> (Get Free Report)<p>Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.</p><h2>See Also</h2><ul><li>Five stocks we like better than Omega Healthcare Investors</li><li>Breakout Stocks: What They Are and How to Identify Them</li><li>Worried About Mag 7 Concentration Risk? This ETF Could Help</li><li>Growth Stocks: What They Are, What They Are Not</li><li>Dell Just Hit a Record in AI Orders—But the Real Test Starts Now</li><li>Dividend King Proctor &amp; Gamble Is A Buy On Post-Earnings Weakness </li><li>Here's Who Wins If Trump's 50-Year Mortgages Come to Market</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Omega Healthcare Investors Right Now?</h2><p>Before you consider Omega Healthcare Investors, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.</p><p>While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Omega Healthcare Investors (NYSE:OHI) reached a new 52-week high of $46.19. Several analysts have given positive ratings, with a consensus rating of 'Moderate Buy' and an average price target of $46.44. The company reported strong Q3 earnings, beating estimates with $0.79 EPS and $311.59 million in revenue. Omega also announced a quarterly dividend of $0.67. Recent insider buying includes CEO C Taylor Pickett and CIO Vikas Gupta. Hedge funds and institutional investors have increased their stakes in the company.</p>

Omega Healthcare Investors (NYSE:OHI) Sets New 52-Week High - Time to Buy?